Works matching IS 00071048 AND DT 2012 AND VI 158 AND IP 2

Results: 21
    1

    Neridronate improves bone mineral density and reduces back pain in β-thalassaemia patients with osteoporosis: results from a phase 2, randomized, parallel-arm, open-label study.

    Published in:
    British Journal of Haematology, 2012, v. 158, n. 2, p. 274, doi. 10.1111/j.1365-2141.2012.09152.x
    By:
    • Forni, Gian Luca;
    • Perrotta, Silverio;
    • Giusti, Andrea;
    • Quarta, Giovanni;
    • Pitrolo, Lorella;
    • Cappellini, Maria Domenica;
    • D'Ascola, Domenico Giuseppe;
    • Borgna Pignatti, Caterina;
    • Rigano, Paolo;
    • Filosa, Aldo;
    • Iolascon, Giovanni;
    • Nobili, Bruno;
    • Baldini, Marina;
    • Rosa, Alessandra;
    • Pinto, Valeria;
    • Palummeri, Ernesto
    Publication type:
    Article
    2

    A prospective, randomized study of empirical antifungal therapy for the treatment of chemotherapy-induced febrile neutropenia in children.

    Published in:
    British Journal of Haematology, 2012, v. 158, n. 2, p. 249, doi. 10.1111/j.1365-2141.2012.09156.x
    By:
    • Caselli, Désirée;
    • Cesaro, Simone;
    • Ziino, Ottavio;
    • Ragusa, Pietro;
    • Pontillo, Alfredo;
    • Pegoraro, Anna;
    • Santoro, Nicola;
    • Zanazzo, Giulio;
    • Poggi, Vincenzo;
    • Giacchino, Mareva;
    • Livadiotti, Susanna;
    • Melchionda, Fraia;
    • Chiodi, Marcello;
    • Aricò, Maurizio
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10

    Tissue microarray analysis reveals protein expression patterns and potential biomarkers of clinical benefit to bortezomib in relapsed/refractory non-Hodgkin lymphoma.

    Published in:
    British Journal of Haematology, 2012, v. 158, n. 2, p. 290, doi. 10.1111/j.1365-2141.2012.09137.x
    By:
    • Gerecitano, John;
    • Gounder, Sivaraman;
    • Teruya-Feldstein, Julie;
    • Arcila, Maria;
    • Ogilvie, Shahiba;
    • Gonzalez, Camille;
    • Lin, Dorothy;
    • Zheng, Junting;
    • Zhang, Zhigang;
    • McDonald, Alice;
    • Mulligan, George;
    • O'Connor, Owen A.
    Publication type:
    Article
    11
    12
    13

    Cloned IGH VDJ targets as tools for personalized minimal residual disease monitoring in mature lymphoid malignancies; a feasibility study in mantle cell lymphoma by the Groupe Ouest Est d'Etude des Leucémies et Autres Maladies du Sang.

    Published in:
    British Journal of Haematology, 2012, v. 158, n. 2, p. 186, doi. 10.1111/j.1365-2141.2012.09161.x
    By:
    • Gimenez, Estelle;
    • Chauvet, Martine;
    • Rabin, Laetitia;
    • Puteaud, Isabelle;
    • Duley, Samuel;
    • Hamaidia, Sieme;
    • Bruder, Juliana;
    • Rolland-Neyret, Valérie;
    • Gouill, Steven;
    • Tournilhac, Olivier;
    • Voog, Eric;
    • Maisonneuve, Hervé;
    • Jacob, Marie C.;
    • Leroux, Dominique;
    • Béné, Marie C.;
    • Formisano-Tréziny, Christine;
    • Gabert, Jean;
    • Gressin, Rémy;
    • Callanan, Mary B.
    Publication type:
    Article
    14
    15

    Leukaemic transformation with romiplostim.

    Published in:
    British Journal of Haematology, 2012, v. 158, n. 2, p. 153, doi. 10.1111/j.1365-2141.2012.09194.x
    By:
    • Gardner, Kate;
    • Mathe, Stanford;
    • Sahu, Satyajit
    Publication type:
    Article
    16
    17
    18
    19

    Phase 1 dose-escalation trial of clofarabine followed by escalating dose of fractionated cyclophosphamide in adults with relapsed or refractory acute leukaemias.

    Published in:
    British Journal of Haematology, 2012, v. 158, n. 2, p. 198, doi. 10.1111/j.1365-2141.2012.09142.x
    By:
    • Zeidan, Amer M.;
    • Ricklis, Rebecca M.;
    • Carraway, Hetty E.;
    • Yun, Hyun D.;
    • Greer, Jacqueline M.;
    • Smith, B. Douglas;
    • Levis, Mark J.;
    • McDevitt, Michael A.;
    • Pratz, Keith W.;
    • Showel, Margaret M.;
    • Gladstone, Douglas E.;
    • Gore, Steven D.;
    • Karp, Judith E.
    Publication type:
    Article
    20

    Bortezomib combined with low-dose cytarabine in Intermediate-2 and high risk myelodysplastic syndromes. A phase I/ II Study by the GFM.

    Published in:
    British Journal of Haematology, 2012, v. 158, n. 2, p. 232, doi. 10.1111/j.1365-2141.2012.09153.x
    By:
    • Natarajan-Amé, Shanti;
    • Park, Sophie;
    • Ades, Lionel;
    • Vey, Norbert;
    • Guerci-Bresler, Agnès;
    • Cahn, Jean-Yves;
    • Etienne, Gabriel;
    • Bordessoule, Dominique;
    • Ravoet, Christophe;
    • Legros, Laurence;
    • Cheze, Stephane;
    • Stamatoullas, Aspasia;
    • Berger, Elisabeth;
    • Schmidt, Aline;
    • Charbonnier, Aude;
    • Chaury, Marie-Pierre;
    • Braun, Thorsten;
    • Fenaux, Pierre;
    • Dreyfus, Francois
    Publication type:
    Article
    21

    Allogeneic haematopoietic stem cell transplantation for chronic lymphocytic leukaemia: outcome in a 20-year cohort.

    Published in:
    British Journal of Haematology, 2012, v. 158, n. 2, p. 174, doi. 10.1111/j.1365-2141.2012.09170.x
    By:
    • Toze, Cynthia L.;
    • Dalal, Chinmay B.;
    • Nevill, Thomas J.;
    • Gillan, Tanya L.;
    • Abou Mourad, Yasser R.;
    • Barnett, Michael J.;
    • Broady, Raewyn C.;
    • Forrest, Donna L.;
    • Hogge, Donna E.;
    • Nantel, Stephen H.;
    • Power, Maryse M.;
    • Song, Kevin W.;
    • Sutherland, Heather J.;
    • Smith, Clayton A.;
    • Narayanan, Sujaatha;
    • Young, Sean S.;
    • Connors, Joseph M.;
    • Shepherd, John D.
    Publication type:
    Article